MedTrace Logo

EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients

NCT02516124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2018-05-01

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness of Autologous Hematopoietic Stem Cell transplantation (AHSCT) for early severe or rapidly progressive Systemic Sclerosis (SSc) as currently performed by different study protocols used across Europe in various EBMT centres through the careful recording and analysis of routinely collected clinical and biological data.

Conditions

Interventions

PROCEDURE

Autologous HSCT

1st AHSCT

Sponsors & Collaborators

  • European Society for Blood and Marrow Transplantation

    lead NETWORK

Principal Investigators

  • Dominique Farge, PhD · EBMT ADWP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2018-01-31
Completion
2018-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02516124 on ClinicalTrials.gov